Total Payments
$15,617
2024 Payments
$1,616
Companies
58
Transactions
746
Medicare Patients
3,560
Medicare Billing
$432,743
Payment Breakdown by Category
Food & Beverage$14,033 (89.9%)
Consulting$1,200 (7.7%)
Travel$228.21 (1.5%)
Research$150.00 (1.0%)
Education$6.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,033 | 740 | 89.9% |
| Consulting Fee | $1,200 | 1 | 7.7% |
| Travel and Lodging | $228.21 | 2 | 1.5% |
| Unspecified | $150.00 | 1 | 1.0% |
| Education | $6.08 | 2 | 0.0% |
Payments by Type
General
$15,467
745 transactions
Research
$150.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $1,752 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,492 | 79 | $0 (2024) |
| Amgen Inc. | $1,174 | 53 | $0 (2024) |
| Lilly USA, LLC | $940.70 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $893.50 | 47 | $0 (2024) |
| Novo Nordisk Inc | $884.99 | 55 | $0 (2024) |
| ABBVIE INC. | $865.26 | 46 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $721.77 | 40 | $0 (2024) |
| PFIZER INC. | $542.46 | 36 | $0 (2024) |
| Astellas Pharma US Inc | $528.82 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,616 | 79 | AstraZeneca Pharmaceuticals LP ($169.84) |
| 2023 | $1,714 | 81 | Lilly USA, LLC ($315.34) |
| 2022 | $3,508 | 103 | Biohaven Pharmaceutical Holding Company Ltd. ($1,752) |
| 2021 | $1,937 | 103 | AbbVie Inc. ($352.67) |
| 2020 | $1,511 | 74 | Allergan, Inc. ($326.15) |
| 2019 | $1,364 | 76 | Amgen Inc. ($134.72) |
| 2018 | $1,828 | 103 | AstraZeneca Pharmaceuticals LP ($255.45) |
| 2017 | $2,140 | 127 | AstraZeneca Pharmaceuticals LP ($413.38) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Analgesic | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.40 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information | Indivior Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 808 | 1,586 | $199,021 | $106,705 |
| 2022 | 19 | 819 | 1,552 | $214,567 | $112,262 |
| 2021 | 26 | 965 | 1,743 | $212,907 | $115,032 |
| 2020 | 24 | 968 | 1,760 | $198,584 | $98,744 |
Total Patients
3,560
Total Services
6,641
Medicare Billing
$432,743
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 280 | 735 | $88,230 | $51,754 | 58.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 43 | 86 | $17,200 | $10,918 | 63.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 34 | 146 | $14,600 | $8,566 | 58.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 57 | 57 | $17,100 | $8,001 | 46.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 42 | 49 | $9,800 | $5,514 | 56.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 26 | 28 | $7,000 | $4,149 | 59.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 20 | 35 | $5,250 | $3,032 | 57.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 14 | 14 | $5,600 | $2,391 | 42.7% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 36 | $5,400 | $2,301 | 42.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,150 | $1,895 | 60.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 21 | 22 | $3,300 | $1,632 | 49.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 39 | 44 | $4,180 | $1,596 | 38.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 105 | $5,250 | $1,284 | 24.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 26 | $2,470 | $1,276 | 51.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 44 | $1,320 | $913.02 | 69.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 62 | $4,216 | $683.64 | 16.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 12 | 12 | $3,000 | $481.14 | 16.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 27 | $1,215 | $136.18 | 11.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 12 | $540.00 | $98.72 | 18.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 25 | $200.00 | $85.25 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 261 | 672 | $80,640 | $47,142 | 58.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 70 | 101 | $25,250 | $14,105 | 55.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 35 | 98 | $19,600 | $10,955 | 55.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $22,600 | $10,944 | 48.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 43 | 165 | $16,500 | $9,055 | 54.9% |
About Dr. William Welsh, D.O
Dr. William Welsh, D.O is a Family Medicine healthcare provider based in Whittier, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568401255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Welsh, D.O has received a total of $15,617 in payments from pharmaceutical and medical device companies, with $1,616 received in 2024. These payments were reported across 746 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($14,033).
As a Medicare-enrolled provider, Welsh has provided services to 3,560 Medicare beneficiaries, totaling 6,641 services with total Medicare billing of $432,743. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine
- Location Whittier, CA
- Active Since 06/06/2006
- Last Updated 09/01/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568401255
Products in Payments
- NURTEC ODT (Drug) $1,920
- FARXIGA (Drug) $825.14
- ENTRESTO (Drug) $562.18
- UBRELVY (Drug) $500.02
- VRAYLAR (Drug) $461.77
- Aimovig (Biological) $444.68
- TRELEGY ELLIPTA (Drug) $428.22
- Ozempic (Drug) $384.02
- Otezla (Drug) $363.10
- XIFAXAN (Drug) $359.47
- Tymlos (Biological) $300.36
- REXULTI (Drug) $298.66
- XARELTO (Drug) $287.16
- JARDIANCE (Drug) $277.38
- MYRBETRIQ (Drug) $275.34
- TRULICITY (Drug) $250.00
- MOUNJARO (Drug) $238.26
- Myrbetriq (Drug) $230.85
- Rybelsus (Drug) $217.01
- EVENITY (Biological) $213.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Whittier
Dr. Sylvia Garcia, M.d, M.D
Family Medicine — Payments: $13,270
Family Medicine $13,270
Dr. Michael Maguire, D.o, D.O
Family Medicine — Payments: $11,063
Family Medicine $11,063
Dr. Matthew Mahar, Md, MD
Family Medicine — Payments: $7,482
Family Medicine $7,482
Gina Tran, Md, MD
Family Medicine — Payments: $5,204
Family Medicine $5,204
Mr. David Abiva, Pa-C, PA-C
Family Medicine — Payments: $4,008
Family Medicine $4,008
Sanjeev Puri, D.o, D.O
Family Medicine — Payments: $1,859
Family Medicine $1,859